RVL Pharmaceuticals plc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Bridgewater, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
RVL Pharmaceuticals plc has filed 323 SEC EDGAR filings since 09 May 2018

SEC filing history

Showing 26-50 of 79 matching filings.

Per page
25
Current page
2
8-K File 001-38709

FORM 8-K

Filing date
16 Aug 2021
Reporting date
16 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38709

FORM 8-K

Filing date
21 Jun 2021
Reporting date
17 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38709

FORM 8-K

Filing date
01 Jun 2021
Reporting date
01 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38709

FORM 8-K

Filing date
13 May 2021
Reporting date
13 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38709

FORM 8-K

Filing date
30 Mar 2021
Reporting date
30 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38709

FORM 8-K

Filing date
09 Mar 2021
Reporting date
09 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38709

FORM 8-K

Filing date
25 Jan 2021
Reporting date
23 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .